What Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for Investors

28d ago, source: Hosted on MSN

However, current investors in FUSN may want to stick around post-acquisition ... pending Fusion shareholder approval and necessary regulatory clearances. When a company is acquired or bought ...

Global Partner Acquisition Corp II - Ordinary Shares - Class A

3d ago, source: U.S. News & World Report

Global Partner Acquisition Corp. II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business ...

Fusion Pharmaceuticals: Market Perform Rating Amid Acquisition and Promising Prostate Cancer Treatment Data

14d ago, source:

Leerink Partners analyst Faisal Khurshid reiterated a Hold rating on Fusion Pharmaceuticals (FUSN – Research Report) on April 9 and set a ...

AACT Ares Acquisition Corporation II

2d ago, source: Seeking Alpha

Ares Acquisition Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business ...

AstraZeneca Looks to Bolster Radiopharmaceutical Capacity as Cancer Drugs Help Q1 Revenue Growth

12h ago, source: precisionmedicineonline

The company is hoping to gain a competitive edge in the radio-conjugate space with the acquisition of Fusion Pharmaceuticals.

Athena Technology Acquisition Corp. II

9d ago, source: Wall Street Journal

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

DT Cloud Acquisition Corp DYCQ

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Inflection Point Acquisition Corp. II (IPXX)

8mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

AstraZeneca to buy Canadian cancer specialist Fusion for $2.4bn

1mon ago, source: The Guardian

Britain’s biggest drugmaker’s latest acquisition will help it ... The Anglo-Swedish company struck an agreement to acquire Fusion Pharmaceuticals, which is developing next-generation ...

ASCB A SPAC II Acquisition Corp.

3d ago, source: Seeking Alpha

A SPAC II Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business ...

Priveterra Acquisition Corp. II - Ordinary Shares - Class A

9mon ago, source: U.S. News & World Report

Priveterra Acquisition Corp. II is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business ...